Table 2.

PBPC Yield and Transfusion Requirements

Variable Prior RadiationrhTPO Group Control GroupP Value*
Median Range N MedianRange N
No. of aphereses to procure  No  1  1-3 22  2  1-5+  14  .0005  
>3 × 106CD34+ cells/kg  Yes  1  1-2  4  3  3-4+ 6  .001  
 All patients  1  1-3  26  3  1-5+ 20  <.0001 
CD34+ × 106/kg/first apheresis  No 3.6  1.3-18  22  1.3  0.3-4.2  14  .0005 
 Yes  5.1  2.4-15  4  0.7  0.6-0.9  4  .014 
 All patients  4.1  1.3-17.6  26  0.8  0.3-4.2 20  .0003  
No. of RBC transfusions No  3  2-7 21  4.5  2-10  14  .07  
 Yes  3.5  3-4 2  4  3-8  6  .37  
 All patients  3  2-7 23  4  2-10  20  .02  
No. of platelet transfusions No  4  0-10  21  5  2-19  14  .09  
 Yes 3  2-4  2  6.5  3-11  6  .2  
 All patients 4  0-10  23  5  2-19  20  .02 
Variable Prior RadiationrhTPO Group Control GroupP Value*
Median Range N MedianRange N
No. of aphereses to procure  No  1  1-3 22  2  1-5+  14  .0005  
>3 × 106CD34+ cells/kg  Yes  1  1-2  4  3  3-4+ 6  .001  
 All patients  1  1-3  26  3  1-5+ 20  <.0001 
CD34+ × 106/kg/first apheresis  No 3.6  1.3-18  22  1.3  0.3-4.2  14  .0005 
 Yes  5.1  2.4-15  4  0.7  0.6-0.9  4  .014 
 All patients  4.1  1.3-17.6  26  0.8  0.3-4.2 20  .0003  
No. of RBC transfusions No  3  2-7 21  4.5  2-10  14  .07  
 Yes  3.5  3-4 2  4  3-8  6  .37  
 All patients  3  2-7 23  4  2-10  20  .02  
No. of platelet transfusions No  4  0-10  21  5  2-19  14  .09  
 Yes 3  2-4  2  6.5  3-11  6  .2  
 All patients 4  0-10  23  5  2-19  20  .02 
*

Comparisons between the rhTPO v control groups were performed using the Wilcoxon rank-sum test. F test, adjusting for prior radiation, was used to combine strata in the overall analysis.

Transfusion requirements were evaluated in 23 assessable patients.

Close Modal

or Create an Account

Close Modal
Close Modal